【摘要】 随着生活方式的改变，肥胖成为多囊卵巢综合征(PCOS)的主要危险因素。肥胖可加剧恶化PCOS患者的不良表型、生殖功能和代谢障碍，尤其是心血管疾病(CVD)风险增加。肥胖、PCOS是CVD的重要危险因素。胰高血糖素样肽-1受体激动剂(GLP-1 RA)具有独特的代谢靶点，可以同时改善肥胖、代谢障碍和生殖功能，降低CVD风险。本文就GLP-1 RA对PCOS相关CVD的影响作一综述。更多还原

【Abstract】 With change of lifestyle, obesity has become a major risk factor for polycystic ovary syndrome(PCOS). Obesity aggravates adverse phenotype, reproductive function and metabolic disorders in PCOS patients, especially increased risk of cardiovascular disease(CVD). Obesity and PCOS are important risk factors of CVD. Glucagon-like peptide-1 receptor agonists(GLP-1 RA) have unique metabolic targets that can simultaneously improve obesity, metabolic disorders and reproductive function, and reduce CVD risk. The present article makes a review on influence of GLP-1 RA on PCOS-related CVD.更多还原